New treatment approved for severe premenstrual symptoms.
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use*; D006801:Humans; D011293:Premenstrual Syndrome / Q000188:drug therapy*
D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine